Key Takeaways Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the ...

Eli Lilly (LLY) ended the recent trading session at $797.48, demonstrating a -0.3% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0. ...

The company anticipates 2025 revenue to be in the range of $58.0 billion to $61.0 billion, growth of 32% at the midpoint compared to expected 2024 revenue ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight ... opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The US Dec PPI final demand rose +0.2% m/m and +3.3% y/y, weaker than expectations of +0.4% m/m and +3.5% y/y. Also, Dec PPI ex-food and energy was unchanged m/m and rose +3.5% y/y, weaker than ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

“We conclude that the information and data Lilly has provided to FDA demonstrate ... according to the Associated Press, prices and ways to access drugs like Zepbound and Mounjaro could be ...

Davone Duangdany, director of the drug and medical device control division within the Laos health ministry, told Reuters that such information ... said prices for Novo's and Lilly's weight-loss ...